Acurx pharmaceuticals, inc. reports second quarter 2023 results and provides business update

Staten island, n.y. , aug. 14, 2023 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the second quarter ended june 30, 2023.

ACXP Ratings Summary

ACXP Quant Ranking